Answers are grounded in this paper and cite their sources.
Case study uncovers mechanisms driving voluntary ethical codes in pharmaceutical governance, challenging reliance on state hierarchical threats.
In 2004, the voluntary FSA Codex was adopted by part of the German pharmaceutical industry and was revised several times in the subsequent 10 years. The codex—as many others in OECD countries do—addresses the delicate relationship between the pharmaceutical industry and physicians. This article presents a case study of the FSA Codex and addresses the question of why this voluntary regulation was adopted and revised. In doing so, the article challenges a strong position in the literature, that voluntary regulation is dependent on the shadow of hierarchy. In addition, it addresses the question how social pressure can trigger voluntary regulation. For this case, rational‐choice institutionalism and normative institutionalism in combination prove useful for identifying the driving forces and causal mechanisms of voluntary regulation.
No takes yet. Share an insight, caveat, or question.
Annette Elisabeth Töller (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: